An Act to restore integrity in the marketing of pharmaceutical products and medical devices
This bill amends Massachusetts state law to update definitions and regulations regarding the marketing of pharmaceutical products and medical devices. It directly affects pharmaceutical and medical device manufacturers, their marketing agents, and health care practitioners by clarifying what constitutes a "gift" and establishing stricter rules for reporting interactions between industry representatives and doctors. The legislation specifically defines terms like "gift" to exclude items of equal value exchanged under explicit contracts and clarifies who qualifies as a health care practitioner or marketer for reporting purposes. By replacing previous sections of Chapter 111N, the bill aims to ensure transparency in how these products are promoted within the state.
Bill status
passed
3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023
Last action Apr 22, 2024
Floor votes
How they voted
This bill passed the House. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
5
Key actions
2
Committee
2
Mar 21, 2024
Upper · Passed
Bill reported favorably by committee and referred to the committee on Health Care Financing
upper
Feb 16, 2023
Lower · Passed
House concurred
lower
Feb 16, 2023
Committee
Referred to the committee on Public Health
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mark Montigny
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1418
Scope: MA
Hi! I can help you understand S 1418. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline